Evidence map›Paper›PMID 29599503›Full record

ArticleNature communications2018

Zeb1-Hdac2-eNOS circuitry identifies early cardiovascular precursors in naive mouse embryonic stem cells.

Chiara Cencioni, Francesco Spallotta, Matteo Savoia, Carsten Kuenne, Stefan Guenther, Agnese Re, Susanne Wingert, Maike Rehage, Duran Sürün, Mauro Siragusa and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.Frontiers in cell and developmental biology · 2020
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Chiara CencioniDivision of Cardiovascular Epigenetics, Department of Cardiology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. chcencioni@gmail.com.
Francesco SpallottaDivision of Cardiovascular Epigenetics, Department of Cardiology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Matteo SavoiaDivision of Cardiovascular Epigenetics, Department of Cardiology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Carsten KuenneECCPS Bioinformatics and deep sequencing platform, Max Planck Institute for Heart and Lung Research, Ludwigstrasse 43, 61231, Bad Nauheim, Germany.
Stefan GuentherECCPS Bioinformatics and deep sequencing platform, Max Planck Institute for Heart and Lung Research, Ludwigstrasse 43, 61231, Bad Nauheim, Germany.
Agnese ReNational Research Council, Institute of Cell Biology and Neurobiology (IBCN), Via del Fosso di Fiorano 64, 00143, Rome, Italy.
Susanne WingertLOEWE Center for Cell and Gene Therapy and Department of Medicine, Hematology/Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Maike RehageLOEWE Center for Cell and Gene Therapy and Department of Medicine, Hematology/Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Duran SürünLOEWE Center for Cell and Gene Therapy and Department of Medicine, Hematology/Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Mauro SiragusaInstitute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Jacob G SmithMRC Laboratory for Molecular Cell Biology, University College London, Gower St, Kings Cross, London, WC1E 6BT, UK.
Frank SchnütgenLOEWE Center for Cell and Gene Therapy and Department of Medicine, Hematology/Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Harald von MelchnerLOEWE Center for Cell and Gene Therapy and Department of Medicine, Hematology/Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Michael A RiegerLOEWE Center for Cell and Gene Therapy and Department of Medicine, Hematology/Oncology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Fabio MartelliMolecular Cardiology Laboratory, IRCCS-Policlinico San Donato, Via Morandi 30 San Donato Milanese, 20097, Milan, Italy.
Antonella RiccioMRC Laboratory for Molecular Cell Biology, University College London, Gower St, Kings Cross, London, WC1E 6BT, UK.
Ingrid FlemingInstitute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0003-1881-3635
Thomas BraunDepartment of Cardiac Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Ludwigstrasse 43, 61231, Bad Nauheim, Germany.
Andreas M ZeiherInternal Medicine Clinic III, Department of Cardiology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Antonella FarsettiNational Research Council, Institute of Cell Biology and Neurobiology (IBCN), Via del Fosso di Fiorano 64, 00143, Rome, Italy. antonella.farsetti@cnr.it.
Carlo GaetanoDivision of Cardiovascular Epigenetics, Department of Cardiology, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. carlo.gaetano@icsmaugeri.it.ORCID http://orcid.org/0000-0002-5238-1832

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) synthesis is a late event during differentiation of mouse embryonic stem cells (mESC) and occurs after release from serum and leukemia inhibitory factor (LIF). Here we show that after release from pluripotency, a subpopulation of mESC, kept in the naive state by 2i/LIF, expresses endothelial nitric oxide synthase (eNOS) and endogenously synthesizes NO. This eNOS/NO-positive subpopulation (ESNO+) expresses mesendodermal markers and is more efficient in the generation of cardiovascular precursors than eNOS/NO-negative cells. Mechanistically, production of endogenous NO triggers rapid Hdac2 S-nitrosylation, which reduces association of Hdac2 with the transcriptional repression factor Zeb1, allowing mesendodermal gene expression. In conclusion, our results suggest that the interaction between Zeb1, Hdac2, and eNOS is required for early mesendodermal differentiation of naive mESC.

Indexed as

AnimalsCell DifferentiationCell Line, TumorHeLa CellsHistone Deacetylase 2HumansLeukemia Inhibitory FactorMiceMouse Embryonic Stem CellsMyocardiumNitric OxideNitric Oxide Synthase Type IIIZinc Finger E-box-Binding Homeobox 1Hdac2 protein, mouseHistone Deacetylase 2Leukemia Inhibitory FactorLif protein, mouseNitric OxideNitric Oxide Synthase Type IIINos3 protein, mouseZEB1 protein, mouseZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID29599503
PMCPMC5876398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.